|Daily Range||$43.10 - $44.43|
|52-Week Range||$31.22 - $52.58|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||417,377|
|Current FY EPS||$9.15|
Enanta Pharmaceuticals, Inc. (ENTA) Description
Enanta Pharmaceuticals, Inc. Website: http://www.enanta.com/
News & Commentary
Gilead's nearly 46% profit margin is among the best in the biotech sector. However, these three biotech stocks currently have Gilead beat.
Gilead Sciences Sovaldi was a superstar in 2014, helping Gilead to nearly a 40% year-to-date return. However, one hepatitis C drug developer has delivered 700% better returns to shareholders this year!
Express Scripts makes AbbVie's Viekira Pak its exclusive hepatitis C drug, excluding Gilead's Harvoni.